BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17039675)

  • 1. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
    Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
    J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
    Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
    J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
    Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
    Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful desensitization to oxaliplatin.
    Mis L; Fernando NH; Hurwitz HI; Morse MA
    Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
    Lee C; Gianos M; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin testing and hypersensitivity reactions to oxaliplatin.
    Garufi C; Cristaudo A; Vanni B; Bria E; Aschelter AM; Santucci B; Terzoli E
    Ann Oncol; 2003 Mar; 14(3):497-8. PubMed ID: 12598359
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
    Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
    J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
    Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
    Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity Reactions to oxaliplatin: incidence and management.
    Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
    Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol.
    Syrigou E; Dannos I; Kotteas E; Makrilia N; Tourkantonis I; Dilana K; Gkiozos I; Saif MW; Syrigos KN
    Int Arch Allergy Immunol; 2011; 156(3):320-4. PubMed ID: 21720178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
    Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
    JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.